More News! 7 Nov 2025 Top biotech deals in October 2025 October saw a wave of M&As and biotech deals in various therapeutic fields, but particularly for therapies addressing autoimmune conditions. November 7, 2025 - 13 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
More News! 27 Aug 2025 Zemcelpro, the first blood cord expansion therapy to reach the EU market Find out about ExCellThera’s zemcelpro, the first blood cord expansion therapy to reach the European market, and only the second globally. August 27, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
More News! 10 Dec 2024 Biotech in 2024: A retrospective 2024 is coming to a close and it is time to look at how biotech performed this year. Was it a triumph or a year of cautious optimism? December 10, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
More News! 26 Jul 2024 Confo Therapeutics raises $60 million to focus on agonistic GPCR antibodies Discover the field of agonistic GPCR antibodies after Confo therapeutics successfully raised $60 million in its series B round. July 26, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
More News! 23 Jul 2024 First AKT-targeting drug capivasertib to hit the market, could it open the door for more? As AstraZeneca and Astex’s capivasertib gains market presence in breast cancer, could it be the time for AKT inhibitors? Let’s find out! July 23, 2024 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
More News! 17 Jul 2024 Is tau protein the key to defeating Alzheimer’s? Asceneuron thinks so and raises $100 million to prove it Discover yet another exciting deal in biotech with Asceneuron raising $100 million to advance its Alzheimer’s candidate, ASN51. July 17, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Jul 2024 Five universities in Canada to build a career in biotech in 2024 Delve into Canada’s biotech education ecosystem with five universities putting industry experience forward. July 12, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
More News! 11 Jul 2024 CDMO trends post-Wuxi’s exit from the US: who will take its place? The BIOSECURE Act is reshuffling the deck and Indian CDMOs are looking good. Discover the trends in this evolving landscape. July 11, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
More News! 27 May 2024 New report shows that Swiss biotech capital investment surged last year With a record revenue of $8 billion in 2023, Swiss biotech appears robust in 2024. Delve into the findings of the Swiss Biotech Report 2024. May 27, 2024 - 5 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Expert Advice 17 May 2024 How to use LinkedIn to ace your biotech job search and advance your career LinkedIn is the most powerful tool to develop your career in the biotech industry. Delve into the strategies to use it efficiently. May 17, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 24 Apr 2024 Overcoming toxicities: are IL-2 smart cytokines the next big thing? A more advanced form of IL-2 cytokine therapy called IL-2 smart cytokines could overcome side effects, and shake up cancer care as we know it. April 24, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
More News! 4 Dec 2023 FDA CAR-T cell therapy warning: Are T cells malignant? Chimeric antigen receptor (CAR) T cell therapies have emerged as groundbreaking treatments for various hematologic cancers, demonstrating remarkable efficacy in targeting specific cancer cells. However, recent concerns raised by the U.S. Food and Drug Administration (FDA) have sparked an investigation into potential risks associated with these therapies. The FDA CAR-T cell therapy warning comes at […] December 4, 2023 - 4 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email